AKT1 and neoplasm: It is likely that in gastric cancer, the loss of SHIP2 PtdIns(3,4,5)P3 5-phosphatase activity leads to enhanced AKT activation, resulting in increased cell proliferation and tumour growth, as observed with PIPP in breast cancer.